Historique
Auteur O. CORAZZA
Documents disponibles écrits par cet auteur (25)
Ajouter le résultat à votre sélection Affiner la recherche
J. M. CORKERY ; S. ELLIOTT ; F. SCHIFANO ; O. CORAZZA ; A. H. GHODSE | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : Périodique2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops as 'legal highs', 'rese[...]
C. T. GALLAGHER ; S. ASSI ; J. L. STAIR ; S. FERGUS ; O. CORAZZA ; J. M. CORKERY ; F. SCHIFANO | 2012
Dans Human Psychopharmacology: Clinical and Experimental (Vol.27, n°2, March 2012) Article : PériodiqueOBJECTIVES: The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the[...]
F. S. BERSANI ; R. SANTACROCE ; M. COVIELLO ; C. IMPERATORI ; M. FRANCESCONI ; R. VICINANZA ; A. MINICHINO ; O. CORAZZA | 2016
Dans Drug Testing and Analysis (Vol.8, n°1-2, January-February 2016) Article : PériodiqueIn a society highly focused on physical appearance, people are increasingly using the so-called performance and image-enhancing drugs (PIEDs) or life-style drugs as an easy way to control weight. Preliminary data from online sources (e.g. websit[...]
O. CORAZZA ; F. SCHIFANO ; M. FARRE ; P. DELUCA ; Z. DAVEY ; C. DRUMMOND ; M. TORRENS ; Z. DEMETROVICS ; L. DI FURIA ; L. H. FLESLAND ; B. MERVO ; J. MOSKALEWICZ ; A. PISARSKA ; H. SHAPIRO ; H. SIEMANN ; A. SKUTLE ; C. PEZZOLESI ; P. VAN DER KREEFT ; N. SCHERBAUM | 2011
PériodiqueBased on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-[...]
M. M. YOUNG ; C. DUBEAU ; O. CORAZZA | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : PériodiqueObjective: To determine the feasibility and utility of using media reports and other open-source information collected by the Global Public Health Intelligence Network (GPHIN), an event-based surveillance system operated by the Public Health Age[...]
Z. DAVEY ; F. SCHIFANO ; O. CORAZZA ; P. DELUCA ; Psychonaut Web Mapping Group | 2012
Dans Journal of Mental Health (Vol.21, n°4, August 2012) Article : PériodiqueBACKGROUND: "Legal highs" are becoming increasingly common features of the recreational drug market. The Internet has emerged as an important resource for technical and pharmacological knowledge in the absence of evidence-based literature, and f[...]
From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine
O. CORAZZA ; S. ASSI ; F. SCHIFANO | 2013
Dans CNS Neuroscience and Therapeutics (Vol.19, n°6, June 2013) Article : PériodiqueThis article reviews the recreational use of ketamine ("Special K"; KET) and explores the recent diffusion of its new derivative methoxetamine ("Special M"; MXE). The literature search on the nonclinical/recreational use of KET and MXE was carri[...]
H. BOWDEN-JONES ; R. W. HOOK ; J. E. GRANT ; K. IOANNIDIS ; O. CORAZZA ; N. A. FINEBERG ; B. F. SINGER ; A. ROBERTS ; R. BETHLEHEM ; S. DYMOND ; R. ROMERO-GARCIA ; T. W. ROBBINS ; S. CORTESE ; S. A. THOMAS ; B. J. SAHAKIAN ; N. A. DOWLING ; S. R. CHAMBERLAIN | 2022
Dans Lancet Psychiatry (The) (Vol.9, n°4, April 2022) Article : PériodiqueGambling in the modern era is pervasive owing to the variety of gambling opportunities available, including those that use technology (eg, online applications on smartphones). Although many people gamble recreationally without undue negative eff[...]
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the seriou[...]
P. DELUCA ; Z. DAVEY ; O. CORAZZA ; L. DI FURIA ; M. FARRE ; L. H. FLESLAND ; M. MANNONEN ; A. MAJAVA ; T. PELTONIEMI ; M. PASINETTI ; C. PEZZOLESI ; N. SCHERBAUM ; H. SIEMANN ; A. SKUTLE ; M. TORRENS ; P. VAN DER KREEFT ; E. IVERSEN ; F. SCHIFANO | 2012
Dans Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol.39, n°2, 3 December 2012) Article : PériodiqueBACKGROUND: This paper presents the outcomes of the 2-year European Union funded Psychonaut Web Mapping Project which aimed at developing and implementing an integrated web mapping system to promptly identify and learn about novel psychoactive s[...]!['Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate [Viewpoint]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=71485)
O. CORAZZA ; Z. DEMETROVICS ; W. VAN DEN BRINK ; F. SCHIFANO | 2013
Dans International Journal of Drug Policy (Vol.24, n°1, January 2013) Article : PériodiqueWe would like to highlight the necessity of reflecting and possibly reconsidering the use of term 'legal highs' in the field of drug prevention and research, as it refers to two ambiguous and undefined characteristics of these products. [Extract]
Z. DAVEY ; O. CORAZZA ; F. SCHIFANO ; P. DELUCA ; Psychonaut Web Mapping Group | 2010
Dans Drugs and Alcohol Today (Vol.10, n°3, September 2010) Article : PériodiqueThe market in licit recreational drugs is continuing to grow, both in the UK and elsewhere, and the internet has been acknowledged as a key factor in enabling this rapid expansion over the last few years. This is particularly true of the recent [...]
F. SCHIFANO ; A. ALBANESE ; S. FERGUS ; J. L. STAIR ; P. DELUCA ; O. CORAZZA ; Z. DAVEY ; J. CORKERY ; H. SIEMANN ; N. SCHERBAUM ; M. FARRE ; M. TORRENS ; Z. DEMETROVICS ; A. H. GHODSE ; Psychonaut Web Mapping Group ; ReDNet Research Group | 2011
Dans Psychopharmacology (Vol.214, n°3, April 2011) Article : PériodiqueBACKGROUND Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; ‘meow meow’ and others) has been seen by some as a cheaper alterna[...]
A. R. WINSTOCK ; L. R. MITCHESON ; P. DELUCA ; Z. DAVEY ; O. CORAZZA ; F. SCHIFANO | 2011
Dans Addiction (Vol.106, n°1, January 2011) Article : PériodiqueAIMS: Mephedrone (4-methylmethcathinone) is a novel synthetic stimulant drug that has recently become popular in the United Kingdom and elsewhere in Europe. It has a short history of human consumption and little is known about its prevalence and[...]
O. CORAZZA ; S. ASSI ; S. MALEKIANRAGHEB ; M. N. BENI ; I. BIGDELI ; Z. ASLANPOUR ; F. SCHIFANO | 2014
Dans International Journal of Drug Policy (Vol.25, n°4, July 2014) Article : PériodiqueBackground: Numbers of novel psychoactive substances (NPS) have been rapidly increasing over the past few years, with unprecedented challenges on traditional drug control systems. The web has been involved in the promotion and knowledge dissemin[...]
